XFOR Competitors & Alternatives
Compare X4 Pharmaceuticals, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
XFOR
Main Stock$4.24
Tradestie Score
57
Market Cap
$81.27M
Revenue Growth
0.8%
Analyst Upside
+175.2%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$347.94
|
$160.70B | 24.8 | 54 | Compare |
|
GILD
Gilead Sciences Inc
|
$139.71
|
$137.92B | 20.7 | 60 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$746.42
|
$46.96B | 38.0 | 56 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.18
|
$24.57B | - | 58 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$177.34
|
$22.61B | 20.9 | 55 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$131.60
|
$13.59B | 28.4 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$43.88
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$49.20
|
$10.74B | - | 57 | Compare |
|
QGEN
QIAGEN N.V.
|
$41.03
|
$10.04B | 19.8 | 63 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.13
|
$9.33B | 100.9 | 59 | Compare |
More XFOR Analysis
Data updated: Apr 02, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry